Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ZBRA | TER |
|---|---|---|
| Price | $376.79 | $409.47 |
| Change today | ▲ 0.93% | ▲ 2.14% |
| Market cap | $17.83B | $64.02B |
| Return, 3 months | +40.7% | -4.1% |
| Return, year to date | +55.2% | +111.8% |
| Return, 1 year | +29.1% | +190.7% |
| P/E (TTM) | 34.5 | 56.2 |
| P/B | 5.2 | 18.6 |
| P/E percentile vs own 5y | 66th | 81st |
| Dividend yield | – | 0.12% |
| Revenue growth (YoY, latest qtr) | +20.4% | +103.9% |
| Net profit growth (YoY) | +108.0% | +378.3% |
| Gross margin | 49.6% | 59.2% |
| Operating margin | 16.6% | 30.9% |
| Net margin | 9.2% | 25.8% |
| Return on equity | 15.3% | 36.7% |
| Analyst target vs. price | +4.8% | +15.8% |
| Analyst buy share | 64% | 67% |
| RSI (14) | 62 | 56 |
| 30-day volatility | 28.3% | 65.3% |
| Max drawdown, 1 year | -38.3% | -34.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
